Sc signals that were clustered at peri-nuclear regions appeared to be localized in an endocytic recycling compartment through which exogenously loaded transferrin, shiga and cholera toxin B subunits were transported. The granular PrP Sc signals at peri-nuclear regions were dispersed to the peripheral regions including the plasma membrane during incubation at 20 6C, at which temperature transport from the plasma membrane to peri-nuclear regions was impaired. Conversely, dispersed PrP Sc signals appeared to return to peri-nuclear regions within 30 min during subsequent incubation at 37 6C, following which PrP Sc at peri-nuclear regions appeared to redisperse again to peripheral regions over the next 30 min incubation. These results suggest that PrP Sc is dynamically transported along with the membrane trafficking machinery of cells and that at least some PrP Sc circulates between peri-nuclear and peripheral regions including the plasma membrane via an endocytic recycling pathway.
INTRODUCTION
Transmissible spongiform encephalopathies (TSEs) are neurodegenerative disorders characterized by neuronal vacuolization, astrocytosis and accumulation of an abnormal isoform of prion protein (PrP Sc ) in the central nervous system. PrP Sc is considered to be a major component of prions, the causative agent of TSE. PrP
Sc is a b-sheet-rich structural isomer of a cellular isoform of the prion protein (PrP C ) and is generated from PrP C that is encoded by the Prnp gene of the host cell (Prusiner, 1998) . Infectivity of prions is thought to be associated with PrP Sc oligomers (Silveira et al., 2005) ; therefore, generation of PrP Sc is a key aspect of prion propagation.
To elucidate the cell biological mechanism of prion propagation, the biosynthesis of PrP C and the generation of PrP Sc have been investigated using cultured cells susceptible to prion infection. A number of biochemical and cell biological analyses have contributed to elucidation of the intracellular dynamics of PrP C (Campana et al., 2005 Korth et al., 1997; Paramithiotis et al., 2003) , these antibodies are not suitable for the detection of PrP Sc by immunocytochemical analysis. Taraboulos et al. (1990) reported that pre-treatment of fixed cells with guanidinium salts significantly increases the PrP Sc signal following immunofluorescence staining. Although the precise reason as to why PrP Sc -specific detection is achieved by this pre-treatment remains unclear, this method is now used for the PrP Sc -specific detection by immunofluorescence assay (IFA) and immunoelectron microscopy. Earlier studies reported that PrP Sc is mainly localized at the plasma membrane, in secondary lysosomes and at a peri-nuclear Golgi region (Fournier et al., 2000; Jeffrey et al., 1992; McKinley et al., 1991; Taraboulos et al., 1990) . However, recent immunocytochemical and immunoelectron microscopy studies showed that PrP Sc is also localized to early endosomes (Veith et al., 2009) , late endosomes/multivesicular bodies (Arnold et al., 1995; Pimpinelli et al., 2005) and to endocytic recycling compartment (ERC) at peri-nuclear regions (Godsave et al., 2008; Marijanovic et al., 2009) .
In spite of the large contribution of this method on elucidation of the localization of PrP Sc in cells, the specificity Fig. 1 . Reactivity of mAbs to PrP in N2a-3 or ScN2a-3-22L cells with or without GdnSCN pre-treatment in IFA. N2a-3 cells and ScN2a-3-22L cells grown in chamber slides were fixed with 4 % paraformaldehyde and then permeabilized with 0.1 % saponin. The cells were treated with 5 M GdnSCN (b, d, f, h, j, l, n, p, r and t) or were left untreated (a, c, e, g, i, k, m, o, q and s), prior to antibody reaction. The anti-PrP mAbs 31C6 (e-h), 44B1 (i-l), 149 (m-p) and 132 (q-t) were used. The mAb P2-284 was used as a negative control (a-d). Cell nuclei were counterstained with DAPI. Merged images of PrP signals (green) and nuclei (blue) are shown. Nearly 100 % ScN2a-3-22L cells were positive for PrP Sc in IFA using mAb 132.
Intracellular localization of PrP
Sc of PrP Sc detection by this method should be carefully reevaluated. In fact, pre-treatment with guanidine hydrochloride (GdnHCl) does not prevent detection of PrP C in uninfected cells (Taraboulos et al., 1990; Veith et al., 2009) . In order to distinguish PrP Sc from PrP C by IFA, the detector gain or the exposure time needs to be adjusted to a level at which PrP C signals are below the detection limit (Marijanovic et al., 2009; Veith et al., 2009) . Alternatively, prior to pre-treatment with denaturants, proteinase K (PK) treatment is required to completely abolish PrP C signals (Taraboulos et al., 1990; Veith et al., 2009) . However, PK treatment affects cell architecture, which makes it difficult to finely analyse localization (unpublished observation). Resolution of these technical limitations will improve the quality of PrP Sc detection in prion-infected cells. Taking these background studies into account, we first investigated the utility of various anti-PrP antibodies that recognize different epitopes on the PrP molecule for PrP Sc -specific detection using IFA. We found that the mAb 132, which recognizes linear epitope consisting of mouse PrP aa 119-127 (Kim et al., 2004b) , the region adjacent to a hydrophobic amino acid sequence of PrP, AGAAAAGA, was the most suitable for this purpose. We therefore extensively analysed the localization of PrP Sc in prion-infected cells using mAb 132. Our results suggest that PrP Sc is trafficked through a cellular compartment at peri-nuclear regions along with the membrane trafficking machinery of the cells.
RESULTS

Specific detection of PrP
Sc in prion-infected cells by IFA Pre-treatment of cells with denaturants such as guanidinium salts (Taraboulos et al., 1990) and formic acid (Kristiansen et al., 2005) prior to antibody reaction facilitates PrP Sc -specific detection in prion-infected cells by IFA, although the precise mechanism by which this method distinguishes PrP
Sc from PrP C remains unclear. However, one concern when using this method is that detection of PrP C cannot be completely excluded as described below. In order to overcome this problem, we evaluated various antiPrP mAbs for more accurate detection of PrP Sc using IFA.
When N2a-3 cells, a subclone of mouse neuroblastoma Neuro2a cell line (Uryu et al., 2007) , without guanidine thiocyanate (GdnSCN) pre-treatment were stained with mAbs 31C6 or 44B1 that react strongly with PrP C expressed on the cell surface, intense PrP C signals were mainly detected at the plasma membrane (Fig. 1e, i ). This membrane staining was not affected by GdnSCN pretreatment (Fig. 1f, j) . This result indicates that PrP C was not removed from the cell surface by GdnSCN pretreatment as described previously (Veith et al., 2009) . When N2a-3 cells persistently infected with the prion 22L strain (ScN2a-3-22L) without GdnSCN pre-treatment were stained with these mAbs, PrP signals were also detected at the cell surface similar to N2a-3 cells (Fig. 1g, k) . However, staining of ScN2a-3-22L cells that were pre-treated with GdnSCN showed intense granular signals at the perinuclear regions (Fig. 1h, l) . In addition to this peri-nuclear staining, weak signals at the cell surface were still detected (Fig. 1h, l) , especially in areas where the cell density was high (data not shown). The presence of PrP signals at perinuclear regions of ScN2a-3-22L cells but not of N2a-3 cells pre-treated with GdnSCN, suggested that these perinuclear signals represent PrP Sc as reported previously (Marijanovic et al., 2009; Taraboulos et al., 1990; Veith et al., 2009) . However, although signals at the plasma membrane of ScN2a-3-22L cells pre-treated with GdnSCN were much weaker than those of N2a-3 cells, the detection of PrP C in N2a-3 cells after GdnSCN pre-treatment may raise a concern regarding distinction of PrP Sc from PrP C . Fig. 2 . PrP Sc -specific detection in prion-infected cells using mAb 132. Non-infected N2a-3 and GT1-7 cells as well as ScN2a-3-22L, ScN2a-3-Ch and ScGT1-7-22L cells, were subjected to PrP Sc -specific staining using mAb 132. (Kim et al., 2004a) . mAb 149 detected faint PrP signals in both N2a-3 and ScN2a-3-22L cells without GdnSCN pre-treatment (Fig. 1m, o) . However, GdnSCN pre-treatment abolished the faint PrP C signals detected in N2a-3 cells, but enhanced strong granular signals at peri-nuclear regions in ScN2a-3-22L cells (Fig. 1n, p) . mAb 132 staining resulted in intense PrP signals at peri-nuclear regions in ScN2a-3-22L cells pre-treated with GdnSCN (Fig. 1t) . Remarkably, this mAb detected little PrP C in N2a-3 cells, regardless of the presence or absence of GdnSCN pre-treatment (Fig. 1q, r) . Moreover, PrP signals in ScN2a-3-22L cells without GdnSCN pre-treatment appeared to be below the detection limit (Fig. 1s) . We also verified the utility of mAb 132 for PrP Sc -specific detection in different prion strains or cell lines (Fig. 2) . Similar to ScN2a-3-22L cells, characteristic granular signals were detected in N2a-3 cells infected with the Chandler strain (ScN2a-3-Ch) and in GT1-7 cells persistently infected with the 22L strain (ScGT1-7-22L), but fluorescent PrP C signals in uninfected cells remained at background level. Since hardly any PrP C signal was detected in uninfected cells even after GdnSCN pretreatment, mAb 132 is believed to enable more precise PrP Sc -specific detection in IFA.
Intracellular localization of PrP Sc
Since mAb 132 enables reliable PrP Sc -specific detection, we used this mAb to analyse the intracellular localization of PrP Sc in ScN2a-3-22L cells. Lamp1, a marker of late endosomes and/or lysosomes, has been reported to colocalize with PrP Sc in prion-infected cells (Pimpinelli et al., 2005) . As expected, some PrP Sc did co-localize with Lamp1 at peri-nuclear and peripheral regions of the cell (Fig. 3 , arrows). However, PrP
Sc that was detected in a region extremely close to the nucleus did not co-localize with Lamp1 ( Fig. 3, arrowheads) .
We further analysed the co-localization of PrP Sc with Rab GTPases that are known to be present in distinct organelles (Stenmark, 2009; Grant & Donaldson, 2009 ). Peri-nuclear PrP Sc partially co-localized with Rab4a, a marker of early endosomes including rapid endocytic recycling endosomes; Rab5a, a marker of early endosomes; Rab7, a marker of late endosomes; Rab9, a marker of late endosomes involved in retrograde transport to the trans-Golgi network; and Rab11a, a marker of ERC (Fig. 3, arrows) . In contrast to the co-localization of PrP Sc with endosomal and lysosomal markers, only a small proportion of PrP Sc co-localized with Tgn38, a marker of the trans-Golgi network. However, peri-nuclear PrP Sc did not appear to co-localize with giantin, a marker of the cis/medial-Golgi (Fig. 3 ).
Flotillin-1 is a protein that is associated with lipid rafts and is known to be present at the plasma membrane, the transGolgi network and in endosomes, lysosomes and lipid droplets (Browman et al., 2007) . In contrast to the partial co-localization of PrP Sc with the endosomal and lysosomal markers described above, a large proportion of PrP Sc appeared to co-localize with flotillin-1 (Fig. 3 ).
PrP
Sc is localized to ERC in the intracellular transport pathway of transferrin (Tfn), Shiga toxin B subunit (StxB) and Cholera toxin B subunit (CtxB)
Recent ultrastructural and immunofluorescence studies have revealed that PrP
Sc is localized in endocytic compartments (Godsave et al., 2008; Marijanovic et al., 2009; Pimpinelli et al., 2005; Veith et al., 2009) . Since PrP Sc is often detected at the peri-nuclear regions very close to but not in the Golgi apparatus, of particular interest is the ERC that is located near the microtubule organizing centre and the Golgi apparatus that is involved in the recycling of membrane lipids and proteins (Grant & Donaldson, 2009 
Intracellular localization of PrP
Sc binds the Tfn receptor that is internalized from the cell surface via clathrin-coated pits, is transported to early endosomes, and is then recycled back to the plasma membrane via the ERC (Maxfield & McGraw, 2004) . When the cells were loaded with Alexa-Fluor-555-conjugated Tfn, Tfn was detected at the peri-nuclear regions 15 min after the initiation of uptake (time 0) and Tfn had almost disappeared 30 min after the removal of Tfn from the medium (Fig. 4a) . Some of the juxtanuclear PrP Sc did colocalize with internalized Tfn at peri-nuclear regions 15 min after Tfn loading, suggesting that the ERC is one of the compartments to which PrP Sc localizes.
Flotillin-1 is reported to be involved in clathrin-independent endocytosis of StxB and CtxB (Glebov et al., 2006; Lin & Guttman, 2010) . StxB and CtxB are known to bind globotriaosylceramide and GM1 ganglioside, respectively, at cell surface and are transported from the plasma membrane to the trans-Golgi network via early endosomes and the ERC (Lieu & Gleeson, 2010; Nichols et al., 2001) . Since PrP Sc clearly co-localized with flotillin-1 (Fig. 3) , we further analysed the localization of PrP Sc with StxB and CtxB. When cells were loaded with StxB at 4 u C and StxB was then internalized by transfer of the cells to 37 u C, StxB partly co-localized with PrP Sc at the peri-nuclear region 10 min after initiation of internalization (Fig. 4b, arrow) . However, co-localization of PrP Sc with StxB was not so clear after further 10 min incubation (Fig. 4b, arrowhead) . Similarly, co-localization of PrP Sc with internalized CtxB was observed at the peri-nuclear regions 15 and 30 min after initiation of internalization, but co-localization was weaker after 60 min (Fig. 4c) . At 15-30 min after initiation of internalization, CtxB at the peri-nuclear regions showed strong co-localization with Rab11a, but after 60 min, it colocalized more strongly with Tgn38. This result suggested that CtxB present at the peri-nuclear regions was mainly in the ERC at 15-30 min, and in the trans-Golgi network at 60 min after initiation of internalization (Fig. 5, 37 u C) . These results indicate that PrP Sc is present in the ERC, which is on the intracellular transport pathway of StxB and CtxB.
PrP
Sc dynamically cycles between peripheral and peri-nuclear regions in ScN2a-3-22L
The presence of PrP Sc in various endocytic compartments, especially in the ERC through which Tfn, StxB and CtxB are transported, suggested that PrP Sc is transported intracellularly by the membrane trafficking machinery of the cell, rather than being a permanent resident of these organelles. To address the association of PrP Sc with the intracellular membrane trafficking machinery, we analysed the localization of PrP Sc in ScN2a-3-22L cells that were incubated at 20 uC. Incubating cells at a low temperature (¡20 u C) impairs the transport of Tfn or StxB from the plasma membrane to peri-nuclear regions (Mallard et al., 1998; Ren et al., 1998; Sipe et al., 1991) . We firstly confirmed that incubation of ScN2a-3-22L cells at 20 u C slowed down the transport of CtxB (Fig. 5) and StxB (data not shown). Following incubation at 37 u C, CtxB was concentrated at the peri-nuclear regions and co-localized with Rab11a within 15-30 min and with Tgn38 within 60 min, after initiation of its uptake. In contrast, CtxB did not co-localize with either Rab11a or Tga38 after 30 min of incubation at 20 u C, but co-localization with Rab11a could be observed 60 min after the start of incubation. In addition, some CtxB still remained at the plasma membrane 60 min after the incubation, indicating that the transport of CtxB from the plasma membrane to peri-nuclear regions had been slowed down. Under this condition, most of the PrP Sc signals disappeared from the peri-nuclear regions and appeared at peripheral regions of the cells, including at the plasma membrane, within 1 h (Fig. 6a, 20 u C/1 h, arrowheads). After subsequent incubation for another hour, some of the PrP Sc seemed to have redistributed to the peri-nuclear regions (Fig. 6a , 20 u C/ 2 h), following which, PrP Sc gradually disappeared again from the peri-nuclear regions over the next 10 h of incubation. Indeed, following this incubation, the majority of PrP Sc redistributed to the peripheral regions of the cells (Fig. 6a , 20 u C/12 h).
When ScN2a-3-22L cells that had been incubated at 20 u C for 12 h were transferred to 37 u C, peri-nuclear PrP Sc signals appeared to increase and PrP Sc signals at the peripheral regions appeared to decrease within 30 min of incubation (Fig. 6a , 37 u C/30 min). Interestingly, after an additional 30 min incubation at 37 u C, some of the PrP Sc reappeared at the peripheral regions including the plasma membrane, although some PrP Sc was still detected at the peri-nuclear regions (Fig. 6a , 37 u C/60 min, arrowheads).
During subsequent 1 h incubation, PrP
Sc signals at the peripheral regions decreased again, and thereafter, signals of PrP Sc at the peri-nuclear regions appeared to revert to the steady-state level (Fig. 6a , 37 u C/120 min). Little PrP C was detected in N2a-3 cells throughout the experimental period (Fig. 6b) , which means that both the peri-nuclear and the peripheral fluorescent signals represent PrP Sc . In spite of the changes in the intracellular distribution of PrP Sc , the amount of PrP-res, a representative of a protease-resistant form of PrP Sc , was unchanged over the experimental period (Fig. 7) . These results suggest that the dynamic changes in the distribution of PrP Sc were not due to major differences in synthesis or degradation of PrP Sc at specific regions of the cell, but were primarily due to the intracellular trafficking of PrP Sc through the peri-nuclear regions.
DISCUSSION
Analysis of the intracellular localization of PrP
Sc is important for the understanding of the cellular mechanism of prion propagation. Taraboulos et al. (1990) Sc detection, we used mAb 132, which recognizes the epitope consisting of mouse PrP aa 119-127, adjacent to the hydrophobic amino acid sequence, AGAAAAGA (Gasset et al., 1992) . Since mAb 132 showed little reactivity with native PrP C on the cell surface, the epitope for mAb 132 is thought to be buried inside the PrP C molecule. Denaturation with GdnSCN was expected to expose the epitope for mAb 132 of PrP C , but in fact, mAb 132 showed little reactivity with PrP C in uninfected cells even after treatment with GdnSCN (Fig. 1) . A reduction in PrP (Dron et al., 2009) . Indeed, this property of the mAb 132 allowed us to perform more precise PrP Sc detection using IFA because the lack of, or trace PrP C signal means that specific manipulation of the threshold setting during data acquisition can be minimized. Since mAb 132 reacts with denatured PrP C and PrP Sc in immunoblotting (Kim et al., 2004b) , the reason why mAb 132 cannot detect PrP C , but can detect PrP Sc , in cells pre-treated with GdnSCN remains unclear. However, one possible explanation is that the epitope for mAb 132 on PrP C may not be exposed by the relatively short denaturation period (10 min exposure to GdnSCN). Alternatively, it is possible that once the epitope for mAb 132 on PrP C has been exposed by denaturation with GdnSCN, PrP C may quickly refold into a conformation that prevents access of mAb 132 to the epitope after the removal of GdnSCN. In contrast, PrP Sc was detected in prion-infected cells after denaturation with GdnSCN ( Fig. 1) , indicating that the epitope-containing region of PrP Sc molecules, unlike that of PrP C , remained antibody-accessible. PrP Sc has been reported to refold into a PrP C -like form after strong denaturation with GdnHCl (Callahan et al., 2001; Kocisko et al., 1996) . Given that short-term exposure of GdnSCN will not completely denature PrP In agreement with previous reports (Marijanovic et al., 2009; Pimpinelli et al., 2005; Taraboulos et al., 1990; Veith et al., 2009) , we confirmed the widespread intracellular distribution of PrP Sc throughout endocytic compartments in prion-infected cells (Fig. 3) . PrP
Sc was not only present in early and late endosomes/lysosomes but also in cellular compartments at the peri-nuclear regions, at least some of which are thought to be the ERC, through which exogenously derived Tfn, StxB and CtxB are transported during their intracellular trafficking (Fig. 4) . In this study, we observed the extensive co-localization of PrP Sc with flotillin-1 in ScN2a-3-22L cells (Fig. 3) . This result is inconsistent with the report by Pimpinelli et al. (2005) , in which PrP Sc in the Chandler strain-infected N2a cells was not co-localized well with flotillin-1. It remains to be elucidated how differences in prion strains and cell types influence the intracellular distribution of PrP Sc .
Recent immunofluorescent and electron microscopy studies have also proposed the presence of PrP Sc at the ERC (Godsave et al., 2008; Marijanovic et al., 2009) . The ERC is a membranous tubular compartment in the vicinity of the nucleus and is defined by the presence of Rab11a and/or Tfn-bound Tfn receptor (Grant & Donaldson, 2009; Murphy et al., 2005) . Some internalized plasma membrane proteins such as Tfn receptor, the LDL receptor and GPIanchored proteins including PrP C are transported from the early endosomes to the ERC and are then sorted to their target sites including the plasma membrane were then incubated at 20 6C for the indicated periods for up to 12 h. After 12 h incubation at 20 6C, the cells were incubated at 37 6C for up to 120 min as indicated. The cells were then fixed and subjected to PrP Sc -specific staining using mAb 132. The upper panels show merged images of PrP Sc (green) and nuclei (blue). The bottom panels show high magnification images of the boxed regions in the corresponding upper panels that were merged with a DIC image. The arrowheads point to representative examples of PrP Sc signals at the cell surface. Bar, 10 mm. (b) Specificity of PrP Sc staining. N2a-3 or ScN2a-3-22L cells cultured on a chamber slide at 37 6C were subsequently incubated at 20 6C for 12 h and then incubated at 37 6C for 60 min. These cells were fixed and subjected to PrP Sc -specific staining using the mAb132. Bar, 10 mm. Fig. 7 . Amount of PrP-res. ScN2a-3-22L cells cultured on 60 mm dishes at 37 6C were transferred to 20 6C and incubated for 1-12 h. After 12 h of incubation, the cells were incubated again at 37 6C for 15-120 min. The cells were lysed at the indicated time points and were subjected to immunoblotting for PrP-res detection. Sample volume equivalent to 4¾10 5 cells were loaded on each lane. A representative immunoblot image is shown on the top and the graph at the bottom shows the level of PrP-res relative to its level at time 0. The means and SD of four independent experiments are depicted.
Intracellular localization of PrP
Sc Prado et al., 2004) . Many proteins that cycle between the intracellular compartments and the cell surface are known to accumulate in the ERC (Maxfield & McGraw, 2004 (Fig. 6 ). PrP Sc granules at the peripheral regions including those at the plasma membrane appeared to increase during incubation at 20 u C, whereas peri-nuclear PrP Sc granules gradually decreased under this condition.
Conversely, peripheral PrP
Sc granules appeared to decrease as PrP Sc granules accumulated at the peri-nuclear regions once the cells were transferred to 37 u C. This drastic alteration in the distribution of PrP Sc during sequential incubation at 20 and 37 u C suggests that PrP Sc is dynamically transported through compartments that exist at the perinuclear regions, at least some of which are thought to be the ERC, by the membrane trafficking machinery of the cell.
Combined with the fact that PrP
Sc is present at the ERC as described above, it is conceivable that at least some of the PrP Sc cycles between peri-nuclear and peripheral regions including the plasma membrane through the ERC, via the endocytic recycling pathway. Marijanovic et al. (2009) There are a few studies which report that PrP Sc was detected in late endosomes or early endosomes/ERC in the brains of prion-infected animals (Arnold et al., 1995; Godsave et al., 2008) . However, intracellular localization of PrP Sc in brains of prion-infected animals is largely unknown. We have confirmed that mAb 132 is also applicable to the PrP Sc -specific detection in brain section of prion-infected animals, and now experiments are under way to extensively analyse the cellular compartments where prions present in the brain of mice infected with prions.
METHODS
Antibodies, reagents and chemicals. Mouse mAbs, 31C6, 44B1, 149 and 132 were used for the detection of PrP. mAbs 31C6, 149 and 132 recognize linear epitopes consisting of mouse PrP aa 143-149, 147-151 and 119-127, respectively, whereas mAb 44B1 recognizes a discontinuous epitope consisting of aa 155-231 (Kim et al., 2004b) . Following antibodies were used for IFA: anti-Lamp1 rat mAb (1D4B; Beckman Coulter); rabbit polyclonal antibodies: anti-Tgn38 (ab16059; Abcam), anti-giantin (PRB-114C; Covance), anti-flotillin-1 (F1180; Sigma), anti-Rab5 ( # 2143), anti-Rab7 ( # 2094) and antiRab11a (#3539) (all three from Cell Signaling Technology), antiRab4a (10347-1-AP) and anti-Rab9 (11420-1-AP) (Proteintech Group Inc.). An affinity purified anti-StxB rabbit polyclonal antibody was prepared from polyclonal antiserum raised by immunizing a rabbit with purified StxB1-H and StxB2-H (Shimizu et al., 2007) . Alexa-Fluor-488-or 546-conjugated goat F(ab9) 2 fragment antimouse IgG, Alexa-Fluor-555-conjugated goat F(ab9) 2 fragment antirabbit IgG and Alexa-Fluor-555-conjugated goat IgG anti-rat IgG (Invitrogen) were used as secondary antibodies for IFA.
Cell culture. Subclones of mouse neuroblastoma cell line Neuro2a, N2a-3 (Uryu et al., 2007) , and of the hypothalamic neuronal cell line GT1, GT1-7 (Schätzl et al., 1997), were used. As prion-infected cells, ScN2a-3-Ch (Uryu et al., 2007) , ScN2a-3-22L (Nakamitsu et al., 2010) and ScGT1-7-22L were used. These prion-infected cells maintain PrP Sc without significant loss of PrP Sc more than 50 passages. However, we usually used these cells of passage history between 10 and 30 times. N2a-derived cells were passaged at a 1 : 10 dilution ratio every 3-4 days and were cultured in Dulbecco's modified Eagle's medium (DMEM; ICN Biomedicals) containing 10 % FBS (Gibco), MEM non-essential amino acids (NEAA; Gibco), penicillin (100 U ml 21 ) and streptomycin (100 mg ml 21 ) (Gibco) at 37 uC in 5 % CO 2 atmosphere. The GT1-7 cells were passaged at a 1 : 5 dilution ratio every 7 days and were cultured in DMEM containing 5 % FBS, 5 % horse serum (Gibco) and penicillin/ streptomycin.
IFA. Cells grown on a Lab-Tek II CC2 eight-well chamber slide (Nunc) were fixed with pre-warmed PBS containing 4 % paraformaldehyde and 4 % sucrose at 37 uC or at room temperature (RT) for 10 min. After removal of the fixation solution, the remaining paraformaldehyde was neutralized with 0.1 M glycine in PBS for 10 min and then the cells were permeabilized with 0.1 % saponin in PBS for 10 min. For the detection of PrP Sc , cells were pre-treated with 5 M GdnSCN for 10 min. The cells were then washed once with PBS and blocked with 5 % FBS in PBS at RT for 30 min. After blocking, the cells were incubated with primary antibodies in PBS containing 0.5 % FBS at 4 uC overnight. Anti-PrP mAbs were used at a concentration of 1 mg ml 21 . A mAb P2-284 (1 mg ml 21 ) against feline panleukopenia virus was used as a negative-control antibody (Horiuchi et al., 1997) . After washing five times with PBS, the cells were incubated with Alexa-Fluor-conjugated secondary antibodies (1 : 1000) at RT for 90 min. For counterstaining of cell nuclei, cells were incubated for 30 min with 5 mg DAPI ml 21 (Invitrogen) in PBS at RT. The samples were then mounted with ProLong Gold antifade reagent (Invitrogen) and covered with coverslips. The samples were examined using a Nikon C1 laser confocal fluorescence microscope (Nikon) or with a Zeiss laser scanning microscope LSM 700 (Zeiss).
Tfn, CtxB and StxB uptake experiments. For analysis of Tfn uptake, cells grown on Lab-Tek chamber slide were washed twice with Opti-MEM (Gibco) and incubated with 10 mg Alexa-Fluor-555-conjugated Tfn (Invitrogen) ml 21 in Opti-MEM at 37 uC for 15 min. The cells were then washed three times with pre-warmed PBS and incubated at 37 uC for up to 30 min. For analysis of the uptake of CtxB, cells grown on a Lab-Tek chamber slide were washed with Opti-MEM and incubated with 2 mg Alexa-Fluor-488-conjugated CtxB (Invitrogen) ml 21 in Opti-MEM at 4 uC for 30 min. For analysis of StxB uptake (Shimizu et al., 2007) , cells grown on a LabTek chamber slide were washed with Opti-MEM and incubated with 2 mg StxB ml 21 in Opti-MEM at 4 uC for 60 min. The medium was then replaced with pre-warmed fresh DMEM and the cells were incubated at 37 uC for up to 60 min.
Immunoblotting of PrP-res. ScN2a-3-22L cells on 60 mm dishes were washed once with PBS, collected using a cell scraper and the cell number was counted. The collected cells were lysed with lysis buffer (Uryu et al., 2007) at 4 uC for 20 min and cell debris was removed by centrifugation at 2000 g. The protein concentration of the lysates was measured using the DC protein assay kit (Bio-Rad) and was adjusted to 1 mg ml 21 . The lysates (300 ml) were digested with 20 mg PK ml 21 at 37 uC for 20 min. The proteolysis was terminated by the addition of Pefabloc (Roche) to 1 mM. The PK-treated lysates were incubated with 0.3 % phosphotungstic acid at RT for 20 min and then centrifuged at 20 000 g for 20 min to precipitate PK-resistant PrP (PrP-res). The pellet was dissolved in SDS sample buffer and boiled for 5 min. A sample volume equivalent to 4610 5 cells was loaded onto a NuPAGE 12 % Bistris gel (Invitrogen). SDS-PAGE was carried out according to the manufacturer's instructions (Invitrogen). Subsequent Western transfer and chemiluminescence were carried out as described previously (Shindoh et al., 2009) .
